ResMed Inc. (LON:0KW4)

Market Cap	28.21B
Revenue (ttm)	3.91B
Net Income (ttm)	1.07B
Shares Out	n/a
EPS (ttm)	7.27
PE Ratio	26.37
Forward PE	22.91
Dividend	1.72 (0.67%)
Ex-Dividend Date	Nov 13, 2025

Volume	72
Average Volume	358
Open	256.83
Previous Close	255.77
Day's Range	255.84 - 258.06
52-Week Range	199.71 - 297.98
Beta	0.87
RSI	52.80
Earnings Date	Jan 22, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KW4

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD